Saturday, 5 May 2012

Erectile Dysfunction-Pfizer Inc-Vivus Inc-Avanafil-Viagra

FDA approves Vivus's fast-acting Viagra rival
Allergic Skin Condition-Erectile Dysfunction-Eczema
A box of Viagra is seen in a pharmacy in Toronto

NEW YORK (Reuters) - Men with erectile dysfunction may not have to plan for sex as far in advance anymore after Vivus Inc won U.S. approval for avanafil, its faster acting rival to Viagra. Avanafil, which will be sold under the brand name Stendra, is the first new drug in the category in a decade. The drug -- which will compete with Pfizer Inc's Viagra, Eli Lilly's Cialis and Levitra, sold by GlaxoSmithKline and Bayer -- gives Vivus, which has struggled to bring a weight loss drug to market, a potentially lucrative commercial product. ... read more..

1 comment:

Unknown said...

It is important when we buy medicine that has complete label and the manufacturing company has a good reputations. Trusting the company is like trusting their product. FDA approved medicine is important too.



All about @ Kamagra

Post a Comment